Details for New Drug Application (NDA): 088483
✉ Email this page to a colleague
NDA 088483 describes ANTABUSE, which is a drug marketed by Odyssey Pharms and Teva Womens and is included in three NDAs. Additional details are available on the ANTABUSE profile page.
The generic ingredient in ANTABUSE is disulfiram. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the disulfiram profile page.
The generic ingredient in ANTABUSE is disulfiram. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the disulfiram profile page.
Summary for 088483
| Tradename: | ANTABUSE |
| Applicant: | Odyssey Pharms |
| Ingredient: | disulfiram |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088483
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Dec 8, 1983 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
